scispace - formally typeset
H

Henning W. Woitge

Researcher at Heidelberg University

Publications -  45
Citations -  3135

Henning W. Woitge is an academic researcher from Heidelberg University. The author has contributed to research in topics: Bone remodeling & Bone resorption. The author has an hindex of 25, co-authored 45 publications receiving 3047 citations. Previous affiliations of Henning W. Woitge include University Hospital of Lausanne & University of Connecticut Health Center.

Papers
More filters
Journal ArticleDOI

Direct, enzyme-linked immunoassay for urinary deoxypyridinoline as a specific marker for measuring bone resorption

TL;DR: The development of an immunoassay based on a monoclonal antibody for free deoxypyridinoline (Dpd) and its use in healthy individuals and patients with bone‐related disorders to measure the urinary excretion of Dpd as an improved assessment of bone resorption rate are described.
Journal ArticleDOI

Serum interleukin 6 is a major predictor of bone loss in women specific to the first decade past menopause.

TL;DR: Epidemiological data show that serum IL-6 is a predictor of postmenopausal bone loss, and that the effect appears to be most relevant through the first post menopause decade.
Journal ArticleDOI

Seasonal variation of biochemical indexes of bone turnover : Results of a population-based study

TL;DR: It is concluded that seasonal variation contributes significantly to the biological variability of bone turnover and needs consideration when interpreting the results of bone marker measurements.
Journal ArticleDOI

Supplementation with oral vitamin D3 and calcium during winter prevents seasonal bone loss: a randomized controlled open-label prospective trial.

TL;DR: In a randomized, open-label 2-year sequential follow-up study of 55 healthy adults, they found that supplementation with oral vitamin D3 and calcium during winter abolished seasonal changes in calciotropic hormones and markers of bone turnover and led to an increase in BMD.
Journal ArticleDOI

Expression and activity of osteoblast-targeted Cre recombinase transgenes in murine skeletal tissues.

TL;DR: The authors' data suggest that Col 2.3-Cre and Col 3.6-Cre transgenic mice may be useful for conditional gene targeting in vivo or for obtaining osteoblast populations for in vitro culture in which a gene of interest has been inactivated.